Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Christina G. Katsiari, Theodora Simopoulou, Ioannis Alexiou & Lazaros I. Sakkas. (2018) Immunotherapy of systemic sclerosis. Human Vaccines & Immunotherapeutics 14:11, pages 2559-2567.
Read now
Read now
Articles from other publishers (26)
Abeer Ghuman, Dinesh Khanna, Celia J F Lin, Daniel E Furst, Ganesh Raghu, Fernando J Martinez, Mauro Zucchetto, Suiyuan Huang, Angus Jennings, Svetlana I Nihtyanova & Christopher P Denton. (2023) Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort. Rheumatology.
Crossref
Crossref
Mingyue Hu, Zhongliu Yao, Li Xu, Muzi Peng, Guiming Deng, Liang Liu, Xueyu Jiang & Xiong Cai. (2023) M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects. Heliyon 9:5, pages e16206.
Crossref
Crossref
Lazaros I. Sakkas & Theodora Simopoulou. 2023. Translational Autoimmunity. Translational Autoimmunity
447
474
.
Y. Allanore. (2022) Esclerodermia sistémica: tratamiento. EMC - Aparato Locomotor 55:4, pages 1-11.
Crossref
Crossref
Lazaros I. Sakkas & Dimitrios P. Bogdanos. (2022) The Role of T Cells in Systemic Sclerosis: An Update. Immuno 2:3, pages 534-547.
Crossref
Crossref
Masanori Funauchi & Koji Kinoshita. (2022) Problems to Consider Before Determining the Regimen of the Treatment for Juvenile Systemic Sclerosis Treatment: A Case Report Where Tocilizumab Monotherapy Succeeded Efficiently and Safely. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 15, pages 117954412110663.
Crossref
Crossref
Monique Hinchcliff, Rolando Garcia-Milian, Stefano Di Donato, Karin Dill, Elizabeth Bundschuh & Francesco Del Galdo. (2021) Cellular and Molecular Diversity in Scleroderma. Seminars in Immunology 58, pages 101648.
Crossref
Crossref
Kylee J.B. Kus, Avery H. LaChance & Ruth Ann Vleugels. (2021) Recognition and Management of Cutaneous Connective Tissue Diseases. Medical Clinics of North America 105:4, pages 757-782.
Crossref
Crossref
Vincent Dauny, Raphael Borie, Marine Forien, Mada Ghanem, Elisabeth Palazzo, Germain Jelin, Philippe Dieudé & Sébastien Ottaviani. (2021) Systemic sclerosis‐associated interstitial lung disease treated with tocilizumab. Internal Medicine Journal 51:6, pages 999-1000.
Crossref
Crossref
Suman Rohilla. (2020)
Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease:
COVID
‐19
. Drug Development Research 82:1, pages 12-26.
Crossref
Crossref
Gali Epstein Shochet, Elizabetha Brook, Becky Bardenstein-Wald & David Shitrit. (2020) TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling. Respiratory Research 21:1.
Crossref
Crossref
Cristina Müller, Roger Schibli & Britta Maurer. (2020) Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?. Pharmaceuticals 13:9, pages 238.
Crossref
Crossref
V. I. Mazurov, I. B. Belyaeva, R. R. Samigullina, A. L. Chudinov & A. M. Dadalova. (2020) Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases. Meditsinskiy sovet = Medical Council:8, pages 102-112.
Crossref
Crossref
Jiancheng Zhang, Bing Xie & Kenji Hashimoto. (2020) Current status of potential therapeutic candidates for the COVID-19 crisis. Brain, Behavior, and Immunity 87, pages 59-73.
Crossref
Crossref
Apostolos Perelas, Richard M Silver, Andrea V Arrossi & Kristin B Highland. (2020) Systemic sclerosis-associated interstitial lung disease. The Lancet Respiratory Medicine 8:3, pages 304-320.
Crossref
Crossref
Sara L. Gale, Huong Trinh, Nitya Mathew, Angelika Jahreis, Celia J. F. Lin & Khaled Sarsour. (2019) Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population. Rheumatology and Therapy 7:1, pages 89-99.
Crossref
Crossref
Apostolos Perelas, Andrea V. Arrossi & Kristin B. Highland. (2019) Pulmonary Manifestations of Systemic Sclerosis and Mixed Connective Tissue Disease. Clinics in Chest Medicine 40:3, pages 501-518.
Crossref
Crossref
Dinesh Khanna, Donald P Tashkin, Christopher P Denton, Martin W Lubell, Cristina Vazquez-Mateo & Stephen Wax. (2019) Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease. Rheumatology 58:4, pages 567-579.
Crossref
Crossref
Yahya Argobi & Gideon P. Smith. 2019. Fibrosis in Disease. Fibrosis in Disease
25
60
.
A. Fernández-Codina, J. Fernández-Fernández & A. Fernández-Pantiga. (2018) Use of tocilizumab in systemic sclerosis: A brief literature review. Revista Clínica Española (English Edition) 218:6, pages 298-304.
Crossref
Crossref
A. Fernández-Codina, J. Fernández-Fernández & A. Fernández-Pantiga. (2018) Utilización de tocilizumab en la esclerosis sistémica: breve revisión de la literatura. Revista Clínica Española 218:6, pages 298-304.
Crossref
Crossref
Galia Zacay & Yair Levy. (2018) Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature. Best Practice & Research Clinical Rheumatology 32:4, pages 563-571.
Crossref
Crossref
Lazaros I. Sakkas, Theodora Simopoulou, Dimitrios Daoussis, Stamatis-Nick Liossis & Spyros Potamianos. (2018) Intestinal Involvement in Systemic Sclerosis: A Clinical Review. Digestive Diseases and Sciences 63:4, pages 834-844.
Crossref
Crossref
Matthew Benesch, Iain MacIntyre, Todd McMullen & David Brindley. (2018) Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation. Cancers 10:3, pages 73.
Crossref
Crossref
Alexandra Forestier, Thomas Guerrier, Mathieu Jouvray, Jonathan Giovannelli, Guillaume Lefèvre, Vincent Sobanski, Carine Hauspie, Eric Hachulla, Pierre-Yves Hatron, Hélène Zéphir, Patrick Vermersch, Myriam Labalette, David Launay & Sylvain Dubucquoi. (2018) Altered B lymphocyte homeostasis and functions in systemic sclerosis. Autoimmunity Reviews 17:3, pages 244-255.
Crossref
Crossref
Mingyue Hu, Zhongliu Yao, Li Xu, Muzi Peng, Guiming Deng, Liang Liu, Xueyu Jiang & Xiong Cai. (2022) M2 Macrophage Polarization in Systemic Sclerosis Fibrosis: Pathogenic Mechanisms and Therapeutic Effects. SSRN Electronic Journal.
Crossref
Crossref